|Articles|October 1, 2012
- BioPharm International-10-01-2012
- Volume 25
- Issue 10
BioPharm International, October 2012 Issue (PDF)
Vaccine Packaging and Delivery Systems
Advertisement
Articles in this issue
about 13 years ago
India Enforces Stricter Patent Lawsabout 13 years ago
A Manufacturing-Capacity Sharing Modelabout 13 years ago
FDA and the Importance of Confidentialityabout 13 years ago
New Era for Generic Drugsabout 13 years ago
Discovery Pipeline: Nanoparticles for Targeted Deliveryabout 13 years ago
Considerations in Vaccine Packaging and Delivery Systemsabout 13 years ago
Sizing the Market for Contract Manufacturingabout 13 years ago
Bringing Innovation to Neglected Disease R&DNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
